Literature DB >> 19548067

Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000-2006.

Masako Iwanaga1, Shin Chiyoda2, Eisuke Kusaba3, Shimeru Kamihira4.   

Abstract

Human T cell leukemia virus type-1 (HTLV-1) is the established cause of adult T cell leukemia/lymphoma. Monitoring time trends in HTLV-1 seroprevalence in blood donors is important to assess the safety of the blood supply in the viral endemic area. We analyzed changes in HTLV-1 seroprevalence in 48415 first-time blood donors who donated blood from 2000 to 2006 in Nagasaki prefecture, an endemic area in Japan. The donors were divided into 10-year birth cohorts: before 1950, 1951-1960, 1961-1970, 1971-1980, and 1981-1990. Among the first-time blood donors, 622 were tested positive for HTLV-1 [overall seroprevalence: 1.28%, (95% CI 1.19-1.39)]. Seroprevalence was significantly high in the birth cohort of before 1950 (6.22%) and declined with birth-year. The time trend of the birth-cohort-specific seroprevalence showed almost no change within each birth cohort, except for the birth cohort of 1981-1990 that showed a significantly declining trend (P for trend = 0.006). Among the birth cohort of 1981-1990, the seroprevalence was stable among those born during 1981-1986 (0.66-0.83%), but was lower among those born during 1987-1990 (0-0.38%). Detail analyses showed that HTLV-1 seroprevalence among blood donors clearly declined in those born after 1987.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548067     DOI: 10.1007/s12185-009-0366-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.

Authors:  S C Lu; C L Kao; L T Chin; J W Chen; C M Yang; J H Chang; S C Hsu; A C Chang; B H Chen
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

2.  Accelerated declining tendency of human T-cell leukemia virus type I carrier rates among younger blood donors in Kumamoto, Japan.

Authors:  S Oguma; Y Imamura; Y Kusumoto; Y Nishimura; K Yamaguchi; K Takatsuki; S Tokudome; M Okuma
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

3.  Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.

Authors:  S Chiyoda; K Kinoshita; S Egawa; J Inoue; K Watanabe; M Ifuku
Journal:  Intern Med       Date:  2001-01       Impact factor: 1.271

4.  Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.

Authors:  Naglaa A Fawaz; Hala Tamim; Wassim Y Almawi
Journal:  Am J Infect Control       Date:  2005-04       Impact factor: 2.918

5.  Evaluation of birth cohort patterns in population disease rates.

Authors:  R E Tarone; K C Chu
Journal:  Am J Epidemiol       Date:  1996-01-01       Impact factor: 4.897

6.  Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study.

Authors:  Y Maeda; M Furukawa; Y Takehara; K Yoshimura; K Miyamoto; T Matsuura; Y Morishima; K Tajima; K Okochi; Y Hinuma
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

7.  HIV-1 seroprevalence among childbearing women in northern Thailand: monitoring a rapidly evolving epidemic.

Authors:  R E Bunnell; S Yanpaisarn; P H Kilmarx; P H Rhodes; K Limpakarnjanarat; R Srismith; T D Mastro; M E St Louis
Journal:  AIDS       Date:  1999-03-11       Impact factor: 4.177

8.  Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

Authors:  S A Glynn; S H Kleinman; G B Schreiber; M P Busch; D J Wright; J W Smith; C C Nass; A E Williams
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

9.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Mother-to-child transmission of human T-cell leukemia virus type-I.

Authors:  S Hino; K Yamaguchi; S Katamine; H Sugiyama; T Amagasaki; K Kinoshita; Y Yoshida; H Doi; Y Tsuji; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-06
View more
  7 in total

1.  Increased all-cause and cancer mortality in HTLV-II infection.

Authors:  Hope H Biswas; Zhanna Kaidarova; George Garratty; Joan W Gibble; Bruce H Newman; James W Smith; Alyssa Ziman; Joy L Fridey; Ronald A Sacher; Edward L Murphy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

2.  The Changing Epidemiology of Human T-Cell Lymphotropic Virus Type 1 Infection in Peruvian Female Sex Workers, 1993-2010.

Authors:  Jenell Stewart; Kristen Heitzinger; Simon Pollett; Martha Calderón; Jorge Alarcón; Thanh G N Ton; Joseph R Zunt
Journal:  Am J Trop Med Hyg       Date:  2016-11-22       Impact factor: 2.345

Review 3.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

4.  Prevalence and Risk Factors for Human T-Cell Lymphotropic Virus (HTLV) in Blood Donors in Brazil-A 10-Year Study (2007-2016).

Authors:  Carolina Miranda; Denise Utsch-Gonçalves; Fabiana Chagas Camargos Piassi; Paula Loureiro; Isabel Gomes; Maísa Aparecida Ribeiro; César de Almeida-Neto; Paula Blatyta; Luiz Amorim; Sheila Oliveira Garcia Mateos; Edward L Murphy; Brian Custer; Anna Barbara F Carneiro-Proietti; Ester C Sabino
Journal:  Front Med (Lausanne)       Date:  2022-03-09

Review 5.  Updates on HTLV-1 Uveitis.

Authors:  Koju Kamoi; Toshiki Watanabe; Kaoru Uchimaru; Akihiko Okayama; Seiko Kato; Toyotaka Kawamata; Hisako Kurozumi-Karube; Noe Horiguchi; Yuan Zong; Yoshihisa Yamano; Isao Hamaguchi; Yasuhito Nannya; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

6.  Clinical Trials and Treatment of ATL.

Authors:  Kunihiro Tsukasaki; Kensei Tobinai
Journal:  Leuk Res Treatment       Date:  2012-01-16

7.  HTLV-1 uveitis.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Front Microbiol       Date:  2012-07-24       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.